Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
21 Nov 24 | LCTX Lineage Cell Therapeutics | Common Shares | Buy | Acquire P | No | No | 0.6 | 40,000 | 24.00 k | 194,842 |
24 May 24 | LCTX Lineage Cell Therapeutics | Common Shares | Buy | Acquire P | No | No | 1.05 | 10,000 | 10.50 k | 154,842 |
7 Mar 24 | LCTX Lineage Cell Therapeutics | Employee Stock Option Common Shares | Grant | Acquire A | No | No | 1.13 | 1,900,000 | 2.15 mm | 1,900,000 |
11 Feb 24 | LCTX Lineage Cell Therapeutics | Common Shares, no par value | Payment of exercise | Dispose F | No | No | 1.08 | 12,806 | 13.83 k | 144,842 |
11 Feb 24 | LCTX Lineage Cell Therapeutics | Common Shares, no par value | Option exercise | Acquire M | No | No | 0 | 31,249 | 0.00 | 157,648 |
11 Feb 24 | LCTX Lineage Cell Therapeutics | RSU Common Shares | Option exercise | Dispose M | No | No | 0 | 31,249 | 0.00 | 62,499 |